Cindy Spittle BS, PhD

Dr. Spittle joined MolecularMD in 2010 as Scientific Affairs Liaison. In her current role as Vice President, Development and Scientific Affairs she provides strategic scientific leadership related to oncology drug development and biomarker trends as well as new technology platforms and products. Her responsibilities include identifying and initiating opportunities to collaborate in clinical biomarker studies with both industry and academic partners. She also oversees the assay development teams, and facilitates scientific communications between external and internal stakeholders.
With over 20 years of experience in oncology biomarker translational research and diagnostic assay development, Dr. Spittle has held leadership positions at Pfizer, Fox Chase Cancer Center, and SmithKline Beecham Clinical Laboratories. She has authored numerous peer-reviewed publications and abstracts, and has been awarded research grants as Principal Investigator. Dr. Spittle holds a BS in Microbiology from The Pennsylvania State University, an ASCP Medical Technology Certification from Pennsylvania Hospital and a Ph.D. in Molecular Biology from Lehigh University.